Brenig Therapeutics, Inc., a clinical-stage drug development company dedicated to advancing innovative small-molecule therapies for neurodegenerative diseases and powered by a novel AI-based discovery ...

Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing this neurological condition.

A new study out of the United States could shift how multiple sclerosis (MS) is detected and treated. Researchers say they’ve ...